Antibody Discovery by Single B Cell Screening on Beacon®
Single B cell screening is a powerful and efficient strategy for generating antigen-specific monoclonal antibodies. Distinguished with fluorescence-activated B cell sorting, the Beacon® platform is based on plasma cell screening, making it easier to obtain antibody genes.
The Beacon® single-cell optofluidic system combines a unique optoelectro positioning (OEP) technology with novel microfluidic technology. It can be used to accurately select single cells on a chip, perform multiple single-cell assays, and export target cells based on specific results. The Beacon® optofluidic platform preserves the diversity of B cells, generating high-quality positive hits at an early stage of discovery and avoiding the loss of “good clones”.
The webinar will cover the following sections: 1. B cell differentiation and development; 2. Mainstream antibody screening platforms; 3. Beacon® platform; 4. Case studies using the Beacon® platform for antibody screening.
Key Learning Points:
1. Understanding the mechanisms, pros, and cons of different antibody screening platforms
2. Mechanisms and applications of the Beacon platform
3. Sino Biological's capacity using Beacon platform
Speaker Biographies
Amy Sheng, Ph.D.
Technical Account Manager at Sino Biological
Dr Amy Sheng is a technical account manager in Sino Biological. Dr Sheng joined Sino Biological in 2021 supporting CRO services and project management in Eastern US region. Prior to joining Sino Biological, she worked in Caprico Biotechnologies as production manager in charge of antibody development and production for flow cytometry. She has a PhD in Molecular and Cell Biology from Georgia Institute of Technology, and is ASCP-certified molecular biologist and ASQ-certified CSSGB.